Clinical characteristics of respiratory syncytial virus infection in neonates and young infants

被引:11
|
作者
Savic, Natasa [1 ]
Jankovic, Borisav [2 ]
Minic, Predrag [1 ]
Vasiljevic, Zorica [3 ]
Sovtic, Aleksandar [1 ]
Pejic, Katarina [2 ]
Sarajlija, Adrijan [4 ]
Gazikalovic, Slobodan [5 ]
机构
[1] Mother & Child Hlth Inst Dr Vukan Cupic, Dept Pulmonol, Belgrade 11070, Serbia
[2] Mother & Child Hlth Inst Dr Vukan Cupic, Dept Neonatol, Belgrade 11070, Serbia
[3] Mother & Child Hlth Inst Dr Vukan Cupic, Lab Clin Microbiol, Belgrade 11070, Serbia
[4] Mother & Child Hlth Inst Dr Vukan Cupic, Dept Metab & Clin Genet, Belgrade 11070, Serbia
[5] Mother & Child Hlth Inst Dr Vukan Cupic, Dept Radiol, Belgrade 11070, Serbia
关键词
respiratory syncytial viruses; infection; infant; newborn; child; preschool; immunologic tests; drug therapy; prognosis; RISK-FACTORS; BRONCHIOLITIS; RSV; CHILDREN; EPIDEMIOLOGY; MANAGEMENT; IMPACT; TRACT; APNEA;
D O I
10.2298/VSP1103220S
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction/Aim. Infection with respiratory syncytial virus (RSV) occurs during the first year of life in 50% of children and 20%-40% of them have signs of lower respiratory tract infection (bronchiolitis or pneumonia). There is an increased risk for complicated course and death from RSV infection in premature infants, especially those with bronchopulmonary dysplasia (BPD) or congenital heart disease. The aim of our study was to analyze clinical characteristics of laboratory confirmed RSV infection in order to evaluate the need for preventive measures in neonates and young infants. Methods. The prospective study included children under age of 12 months admitted to our hospital in the period November 2008 March 2009 who were positive for RSV by enzyme immunoassay membrane test. The course of disease was assessed by clinical score and radiographic findings. Results. Infection with RSV was confirmed in 91 patients: 21 (23.0%) were under the age of 30 days, 37 (40.7%) were between 31-60 days, and 33 patients (36.3%) were older than 60 days (p > 0.05). The highest hospitalization rate was in January - 33 patients (36.3%; p < 0.01). Disease severity score in these age groups (AG) were: 8.4 +/- 0.4 (AG 0-30 days); 9.0 +/- 0.3 (AG 31-60 days) and 8.3 +/- 0.3 (AG > 60 clays), without statistically significant difference among the groups (p > 0.05). Clinical scores in patients with and without risk factors were 10.5 +/- 0.5 and 8.3 +/- 0.2, respectively (p < 0.01).
引用
收藏
页码:220 / 224
页数:5
相关论文
共 50 条
  • [41] Incidence and severity of pertussis in infants with a respiratory syncytial virus infection
    Moreno Samos, Maria
    Amores Torres, Maria
    Pradillo Martin, Maria Cristina
    Moreno-Perez, David
    Cordon Martinez, Ana
    Urda Cardona, Antonio
    Ramos Fernandez, Jose Miguel
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (07): : 476 - 479
  • [42] Risk factors for severe respiratory syncytial virus infection in infants
    Aujard, Y
    Fauroux, B
    [J]. RESPIRATORY MEDICINE, 2002, 96 : S9 - S14
  • [43] THE ASSOCIATION OF APNEA AND RESPIRATORY SYNCYTIAL VIRUS-INFECTION IN INFANTS
    ANAS, N
    BOETTRICH, C
    HALL, CB
    BROOKS, JG
    [J]. JOURNAL OF PEDIATRICS, 1982, 101 (01): : 65 - 68
  • [44] Hospitalization for respiratory syncytial virus infection in young children - Development of a clinical prediction rule
    Rietveld, E
    Vergouwe, Y
    Steyerberg, EW
    Huysman, MWA
    de Groot, R
    Moll, HA
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (03) : 201 - 207
  • [45] Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection
    Kubota, Jun
    Takahashi, Sho
    Suzuki, Takayuki
    Ito, Akira
    Akiyama, Naoe
    Takahata, Noriko
    [J]. PLOS ONE, 2022, 17 (05):
  • [46] Respiratory syncytial virus infection in infants hospitalized with respiratory illness in northern Jordan
    Meqdam, MMM
    Rawashdeh, MO
    Masaadeh, H
    Shurman, AA
    Abuharfeil, N
    [J]. JOURNAL OF TROPICAL PEDIATRICS, 1998, 44 (02) : 92 - 95
  • [48] Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children
    Englund, Janet A.
    Cohen, Rachel A.
    Bianco, Veronique
    Domachowske, Joseph B.
    Langley, Joanne M.
    Madhi, Shabir A.
    Zaman, Khalequ
    Bueso, Agustin
    Ceballos, Ana
    Cousin, Luis
    Gandhi, Sanjay
    Gruselle, Olivier
    Jose, Lisa
    Klein, Nicola P.
    Koen, Anthonet
    Puthanakit, Thanyawee
    Shi, Meng
    Silas, Peter
    Tangsathapornpong, Auchara
    Teeratakulpisarn, Jamaree
    Vesikari, Timo
    Haars, Gerco
    Leach, Amanda
    Stoszek, Sonia K.
    Dieussaert, Ilse
    [J]. JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2023, 12 (05) : 273 - 281
  • [49] Development of a Global Respiratory Severity Score for Respiratory Syncytial Virus Infection in Infants
    Caserta, Mary T.
    Qiu, Xing
    Tesini, Brenda
    Wang, Lu
    Murphy, Amy
    Corbett, Anthony
    Topham, David J.
    Falsey, Ann R.
    Holden-Wiltse, Jeanne
    Walsh, Edward E.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (05): : 750 - 756
  • [50] Safety, efficacy and pharmacokinetics of palivizumab in off- label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial
    Mori, Masaaki
    Yoshizaki, Kanako
    Watabe, Shinichi
    Ishige, Mika
    Hinoki, Akinari
    Kondo, Takuya
    Taguchi, Tomoaki
    Hasegawa, Hisaya
    Hatata, Tomoko
    Tanuma, Naoyuki
    Kirino, Kosuke
    Hirakawa, Akihiro
    Naruto, Takuya
    Imai, Minoru
    Koike, Ryuji
    Hosoi, Kenichiro
    Kusuda, Satoshi
    [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 39